Associate Professor Caroline Baker FRACS
Clinical Program Director, Surgical Services
Director of Breast Surgery St Vincent’s Hospital
Designated Surgeon St Vincent’s BreastScreen
President, BreastSurgANZ
Associate Professor Caroline Baker is Head of Breast Surgery at St Vincent’s Public Hospital Melbourne, after having serving for 6 years as Director of Breast Services at the Olivia Newton John Cancer and Wellness Centre. She is also Chief Surgeon to St Vincent’s Breast Screen . She gained her FRACS in 1994, then spent 5 years in The UK, subspecialising in the emerging field of breast surgery under the mentorship Mr. Mark Kissin and at The Royal Marsden Hospital in London.
Caroline is a foundation member of BreastSurgANZ, a longterm member of the Australasian Society of Breast Diseases and has been a member of BCT/ANZBCTG since 1998. Caroline regularly teaches students, junior doctors and registrars through The University of Melbourne, lymphoedema practitioners, nurses and volunteers within the Breast Cancer Network of Australia. She has a special interest in neoadjuvant therapy, lymphedema prevention and multidisciplinary care.

Mr Michael Boland completed his undergraduate training in University College Dublin in 2010 and completed Higher Surgical Training in Ireland in 2021. He undertook a competitively appointed TIG National Breast Oncoplastic Fellowship in Imperial College London in 2022, where he was subsequently appointed as a Consultant Oncoplastic Breast Surgeon. He commenced his post as a Consultant Oncoplastic Breast Surgeon in SVPH in Summer 2023.
Areas of interest include oncoplastic treatment of breast cancer with a specific focus on breast conserving surgery with mammoplasty, partial/whole breast reconstruction as well as a special interest in the management of axillary disease.

Judy C. Boughey, M.D., is a breast surgeon and professor of surgery at Mayo Clinic. She is the program director of the breast surgical oncology fellowship at Mayo Clinic and is the immediate past-president of the American Society of Breast Surgeons and sits on the ASBrS Board of Directors. She is chair of the American College of Surgeons Clinical Research Program and a member of the American Surgical Association. Dr. Boughey is recognized with the distinction of the W.H. Odell Professorship in Individualized Medicine.
Dr. Boughey has led multiple national clinical trials; ACOSOG Z1071 evaluating sentinel node surgery in node-positive breast cancer treated with neoadjuvant chemotherapy, ACOSOG Z11102 evaluating breast conservation in multiple ipsilateral breast tumors and ALLIANCE A11202 comparing axillary dissection to axillary radiation for node-positive disease after neoadjuvant chemotherapy. She is author of over 400 peer-reviewed papers.

Peter Chin is the lead breast surgeon at Tauranga Hospital, New Zealand . He graduated from the University of Melbourne and gained post-fellowship experience at the Edinburgh Breast Unit. Peter is an executive director of the Australasian Society for Breast Disease, a member of the Oncoplastic subcommittee of BreastSurgANZ and is an honorary lecturer with the University of Auckland. He is a passionate teacher in Oncoplastic surgery, having convened several Oncoplastic workshops and contributed to the University of Sydney’s Breast course. Peter performs a wide range of Oncoplastic procedures including Therapeutic Mammaplasty, Perforator flaps, fat grafting, Implant-based as well as autologous Lat Dorsi Flap reconstruction.

Dr. Javier Cortes received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996. He continued his studies at the University of Navarra, specialising in Medical Oncology at the Clínica Universitaria de Navarra, where he continued as Assistant in the Department of Oncology from 2002. He was Associated Professor of Oncology in the Faculty of Medicine at the University of Navarra during that period. Dr. Cortés was awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. Since 2003, he has worked in the Department of Medical Oncology at the Hospital Vall d’ Hebron, Barcelona, where he is Coordinator of the Teaching and Training Programme for Residents in Oncology and Senior Specialist in the Area of Breast Cancer with a special interest in New Drugs Development. Dr. Cortés is Head of the Breast Cancer Unit and the Melanoma Unit.
In addition, he has two masters’ degree: “Medical Direction and Clinical Management” by the Universidad Nacional de Educación a Distancia (UNED) and “Research methodology in Health Sciences” by the Universidad Autonoma de Barcelona and a degree in “Statistics in Health Sciences” by the Universidad Autonoma de Barcelona.
Dr. Cortes is the author of more than 100 publications, especially about breast tumours and new drugs and more than 250 communications at different conferences. He actively participates in the development of numerous national and international clinical investigations, especially in relation to drugs directed against molecular targets and new chemotherapy agents, and he is an ad hoc reviewer of various oncology journals.
Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO), a member of the Scientific Committee of the European Society of Medical Oncology and the Scientific Committee of SOLTI group.

Dr Steven David is a radiation oncologist who graduated from the University of Western Australia before completing his specialist training at the Peter MacCallum Cancer Centre in Melbourne. Subsequently, he took up a position as a sub-specialist in breast and lung cancer at the Peter MacCallum Moorabbin campus (Monash Cancer Centre). Steven has been the lead investigator in a number of local clinical trials and has been involved in recruitment to a number of international trials. His current areas of research include development and implementation of a Deep Inspiration Breath Hold Technique to reduce radiation to the heart for patients with left sided breast cancer and the use of high dose precision radiation (SABR) for the treatment of patients with metastatic disease.

Dr. Richard De Boer completed his basic medical and oncology training at the Royal Melbourne Hospital and then in 1997 undertook a 3-year breast and lung cancer clinical research fellowship at the Royal Marsden Hospital in London, working with Professor Ian Smith.
He returned to Melbourne in 2000 and since then has been a consultant medical oncologist working in both public and private practice. His primary areas of clinical interest are in breast and lung cancer, with breast cancer interests focusing on endocrine therapy and mechanisms of resistance, treatment-induced bone loss and bone metastases, and biological predictors of response/survival. He is actively involved in clinical research, and is a member of the Australian New Zealand Breast Cancer Trials Group, and head of the Breast Trials group of Cancer Trials Australia. He has authored or co-authored articles appearing in journals such as the Journal of Clinical Oncology, Annals of Oncology, The Breast and British Journal of Cancer.

Naamit Kurshan Gerber, MD is a Professor of Radiation Oncology at NYU Langone Medical Center where she serves as the Vice Chair for Education and Residency Program Director. Dr. Gerber received her AB in the history of science from Harvard College and her M.D. from the Icahn School of Medicine at Mount Sinai. She completed her residency in radiation oncology at Memorial Sloan Kettering Cancer Center. Dr. Gerber is the co-leader for the breast cancer disease management group at the Perlmutter Cancer Center at NYU. She is currently serving as the chair of the breast education committee for ASTRO and serves as a member of the NRG Breast local regional committee. She is a senior editor for Practical Radiation Oncology for breast cancer and the founding editor for the journal’s Morbidity and Mortality Column.

Jenny Gilchrist is a highly experienced Nurse Practitioner specialising in breast oncology, with over 20 years’ experience across oncology and palliative care. She is committed to advancing clinical trials and improving patient care, quality of life, and outcomes.
Jenny serves on the Executive Board of the Australasian Society of Breast Diseases, is a member of the Scientific Advisory Committee for Breast Cancer Trials, and sits on the Strategic Advisory Group for Breast Cancer Network Australia. She has contributed to the ABC7 and ABC8 international consensus panels, helping shape global guidance for metastatic breast cancer care. From 2019 to 2024, she was Chief Clinical Lead – Metastatic at the McGrath Foundation, supporting the national expansion of metastatic McGrath Breast Care Nurses.